Home >> Marketplace Directory >> Vitros insulin assay gets FDA clearance, 10/17

Vitros insulin assay gets FDA clearance, 10/17

image_pdfCreate PDF

 

October 2017—Ortho Clinical Diagnostics announced that its Vitros Immunodiagnostic Products Insulin Reagent and Calibrators have received FDA clearance and the CE mark. The assay is expected to be commercially available for use on all of the company’s Vitros immunodiagnostic and integrated systems in Europe, in other countries accepting the CE mark, and in the U.S. during the third quarter of this year.

The Vitros Insulin Assay is part of the Vitros Systems’ diabetes menu, which includes HbA1c, glucose, and microalbumin. It can also help to assess a broad range of metabolic conditions, including pancreatic tumors, liver disease, acromegaly, Cushing’s disease, familial glucose-galactose malabsorption, and obesity.

Ortho Clinical Diagnostics, 800-828-6316

CAP TODAY
X